Effect of Nebulized and Intravenous Hypertonic Saline 3% on the Management of Patients With Acute Respiratory Distress Syndrome

Conditions: Nebulization; Hypertonic Saline; Acute Respiratory Distress Syndrome Interventions: Drug: Hypertonic saline 3% nebulizer; Drug: Intravenous hypertonic saline 3% Sponsors: Tanta University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials